Terns’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Terns is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and liver diseases. Read more

Senthil Sundaram's photo - CEO of Terns

CEO

Senthil Sundaram

CEO Approval Rating

90/100

Founded:

2017

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

bluebird bio is the biggest rival of Terns. bluebird bio is headquartered in Cambridge, Massachusetts, and was founded in 1992. Like Terns, bluebird bio also operates in the Biotechnology space. bluebird bio generates 8,876% the revenue of Terns.

Inovio is Terns's #2 competitor. Inovio is a Public company that was founded in Plymouth Meeting, Pennsylvania in 1979. Like Terns, Inovio also works within the Biotechnology sector. Inovio has 176 more employees vs. Terns.

Kite Pharma has been one of Terns's top competitors. Kite Pharma's headquarters is in Santa Monica, California, and was founded in 2009. Kite Pharma is in the Pharmaceuticals field. Kite Pharma generates 1,666% of Terns's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Adaptimmune a competitor of Terns?

Acquisitions

No recent acquisitions found related to Terns

Terns Funding History

$110M

Since Terns was founded in 2017, it has participated in 2 rounds of funding. In total Terns has raised $110.0M. Terns' last funding round was on Oct 2018 for a total of $80.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Oct 2018
$80M

Vivo Capital

Series A
Apr 2018
$30M
-

Total Funding: $110M

Since Terns was founded in 2017, it has participated in 2 rounds of funding. In total Terns has raised $110.0M. Terns' last funding round was on Oct 2018 for a total of $80.0M

Investments

No recent investments found related to Terns

Terns News

July 30, 2020Drug Genius

TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase 1 Clinical Trial

Phase 1 repeated dosing of Voriconazole Inhalation Powder of up to 80 mg/dose in healthy subjects for... See more »
July 28, 2020State of Affairs

Terns Pharmaceuticals and Hansoh Pharma Announce Collaboration and License Agreement for TRN-000632 in Greater China

-TRN-000632 is a potent allosteric inhibitor of BCR-ABL in development for the treatment of CML- -Ter... See more »
June 19, 2020State of Affairs

Terns Pharmaceuticals Initiates the LIFT Study, a Phase 2a Clinical Trial of TERN-101 for the Treatment of NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing... See more »
May 25, 2020MarketScreener

Terns Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference

(marketscreener.com) Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on disco... See more »
April 9, 2020Good Stock Invest

2019 annual financial results and update on the activities of the Company

RESOLVE-IT Phase 3 clinical trial interim results expected by the end of May 2020 Cash position at € ... See more »
March 6, 2020MarketScreener

Terns Pharmaceuticals to Present Data from an Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

(marketscreener.com) Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on disco... See more »
February 21, 2020Pharmabiz

Terns Pharma completes phase 1 study of TERN─101 to treat NASH

Terns Pharmaceuticals, a global biopharmaceutical company focused on discovering and developing innov... See more »

Terns Press Releases

Headquarters

1065 East Hillsdale Suite 100

Foster City, California94404

1-650-275-4395

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Terns is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer and liver diseases. Terns was founded in 2017. Terns' headquarters is located in Foster City, California, USA 94404. It has raised 110.0M in...

CEO

Terns's CEO, Senthil Sundaram, currently has an approval rating of 90%. Terns's primary competitors are bluebird bio, Inovio & Kite Pharma.

Website

ternspharma.com

Frequently Asked Questions about Terns

  1. When was Terns founded?

    Terns was founded in 2017
  2. Who is Terns's CEO?

    Terns's CEO is Senthil Sundaram
  3. How much revenue does Terns generate?

    Terns generates $2.7M in revenue
  4. How much funding does Terns have?

    Terns has historically raised $110M in funding
  1. Where is Terns's headquarters?

    Terns's headquarters is in Foster City California, USA
  2. How many employees does Terns have?

    Terns has 14 employees
  3. What sector does Terns operate in?

    Terns is in Biotechnology
  4. Who are Terns's competitors?

    Terns's top competitors are bluebird bio, Inovio, Kite Pharma